Mark W Hahn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark W Hahn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark W Hahn. Mark W Hahn is CFO, VP of Finance and Admin in GIGABEAM CORP ($GGBM) and EVP and CFO in CEMPRA, INC. ($CEMP) and Chief Financial Officer in Verona Pharma plc ($VRNA) and Chief Financial Officer in Dova Pharmaceuticals, Inc. ($DOVA).
Latest Insider Trading Transactions of Mark W Hahn
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DOVA, GGBM, MLNT, VRNA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Off ... | Sell | S | 1.14 | 26,728 | 30,571 | 19,054,504 | 19.1 M to 19.1 M (-0.14 %) |
| Feb 01 2021 | VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Off ... | Grant | A | 0.00 | 105,824 | 0 | 19,081,232 | 19 M to 19.1 M (+0.56 %) |
| Jan 08 2019 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Option Exercise | A | 8.82 | 250,000 | 2,205,000 | 250,000 | |
| Jan 08 2019 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Grant | A | 0.00 | 8,844 | 0 | 11,344 | 2.5 K to 11.3 K (+353.76 %) |
| Dec 21 2018 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Buy | P | 6.28 | 2,500 | 15,700 | 2,500 | 0 to 2.5 K |
| Oct 10 2018 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Option Exercise | A | 20.42 | 50,000 | 1,021,000 | 50,000 | |
| Oct 10 2018 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Option Exercise | A | 20.42 | 50,000 | 1,021,000 | 50,000 | |
| Feb 01 2018 | DOVA | Dova Pharmaceutica ... | Hahn Mark W | Chief Financial Off ... | Option Exercise | A | 31.86 | 175,000 | 5,575,500 | 175,000 | |
| Feb 27 2017 | CEMP | CEMPRA, INC. | Hahn Mark W | EVP and CFO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 27 2017 | CEMP | CEMPRA, INC. | Hahn Mark W | EVP and CFO | Option Exercise | A | 3.15 | 25,000 | 78,750 | 25,000 | |
| Jan 05 2017 | CEMP | CEMPRA, INC. | Hahn Mark W | EVP and CFO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 05 2017 | CEMP | CEMPRA, INC. | Hahn Mark W | EVP and CFO | Option Exercise | A | 3.00 | 125,000 | 375,000 | 125,000 | |
| Jan 05 2016 | CEMP | CEMPRA, INC. | Hahn Mark W | EVP and CFO | Option Exercise | A | 31.13 | 59,660 | 1,857,216 | 59,660 | |
| Feb 04 2008 | GGBM | GIGABEAM CORP | Hahn Mark W | CFO, VP of Finance ... | Option Exercise | A | 0.41 | 1,000,000 | 410,000 | 666,666 | |
| Feb 04 2008 | GGBM | GIGABEAM CORP | Hahn Mark W | CFO, VP of Finance ... | Option Exercise | A | 0.41 | 1,000,000 | 410,000 | 500,000 |
Page: 1